Immunohistochemistry (IHC) is a widely used laboratory technique that helps detect specific proteins within tissue samples using antigen-antibody interactions. It plays a critical role in disease diagnosis, cancer classification, biomarker evaluation, and biomedical research. Because IHC results directly influence clinical decisions and scientific findings, laboratories must maintain high standards of quality and consistency throughout the testing process. One of the most effective ways to achieve this is through the proper use of IHC controls.

IHC controls are reference samples included in each staining procedure to verify that the assay is functioning correctly. They help identify technical errors, confirm antibody performance, and ensure accurate interpretation of staining results. Following best laboratory practices for using IHC controls improves reliability, enhances diagnostic confidence, and supports compliance with quality assurance standards.

Understand the Different Types of IHC Controls

Before implementing best practices, laboratory personnel should understand the purpose of the three primary types of IHC controls.

Positive controls are tissues known to express the target antigen. These controls confirm that the staining procedure, antibodies, and detection system are working properly. A successful positive control demonstrates that the expected staining pattern can be achieved.

Negative controls are used to detect nonspecific staining or background signal. They often involve omitting the primary antibody or replacing it with a non-immune antibody. Negative controls help distinguish true antigen expression from staining artifacts.

Internal controls are naturally occurring cells or tissue structures within the patient specimen that consistently express the target antigen. These controls provide immediate confirmation that the staining process worked correctly within the same sample.

Using all appropriate controls together provides a comprehensive assessment of assay performance.

Select High-Quality Control Tissues

The effectiveness of IHC controls depends on the quality of the control tissue. Laboratories should use well-characterized tissue samples with documented antigen expression. Positive control tissues should consistently produce predictable staining intensity and distribution.

Control tissues should be processed, fixed, embedded, and stored under standardized conditions to minimize variability. Damaged, poorly preserved, or improperly fixed tissues can produce misleading results and reduce confidence in assay performance.

Many laboratories maintain validated control tissue banks to ensure consistent availability of reliable control materials.

Validate New Antibodies and Reagents

Every new antibody, detection kit, or reagent introduced into the laboratory should undergo thorough validation before routine clinical use. Validation involves testing the reagent with appropriate positive and negative controls across multiple runs.

During validation, laboratories evaluate staining intensity, specificity, sensitivity, reproducibility, and background staining. Optimization of antibody dilution, antigen retrieval methods, incubation times, and detection systems helps establish standardized protocols.

Proper validation minimizes the risk of inaccurate staining when new reagents are implemented.

Include Controls in Every Staining Run

One of the most important laboratory practices is incorporating appropriate perfusion vs immersion fixation for immunohistochemistry pros cons into every IHC staining batch. Even when using automated staining systems, technical issues can occur due to reagent degradation, equipment malfunction, or procedural errors.

Running controls with every batch allows laboratories to verify that staining conditions remain stable and that unexpected results are detected immediately.

If control results do not meet established acceptance criteria, patient results should not be reported until the issue has been investigated and resolved.

Standardize Laboratory Procedures

Consistency is essential for reliable IHC testing. Laboratories should develop detailed standard operating procedures (SOPs) covering every stage of the staining process, including:

• Tissue fixation
• Section preparation
• Antigen retrieval
• Antibody incubation
• Detection methods
• Counterstaining
• Quality control review

Following standardized protocols reduces variability between technicians, instruments, and testing days. Staff should receive regular training to ensure procedures are performed consistently.

Monitor Equipment Performance

Reliable equipment is just as important as high-quality reagents. Automated stainers, incubators, water baths, microscopes, and other laboratory instruments should undergo routine maintenance, calibration, and performance verification.

Equipment failures can alter staining quality and compromise control results. Preventive maintenance schedules help identify potential problems before they affect patient testing.

Documentation of maintenance activities also supports laboratory accreditation requirements.

Document and Review Control Results

Accurate recordkeeping is a key component of quality management. Laboratories should document control performance for every staining run, including staining intensity, localization, and any observed abnormalities.

Regular review of control records helps identify gradual performance changes that may indicate reagent deterioration or instrument problems. Trend analysis allows laboratories to address issues proactively before they affect diagnostic accuracy.

Maintaining complete documentation also facilitates internal audits and external inspections.

Participate in Quality Assurance Programs

External quality assessment (EQA) and proficiency testing programs provide valuable opportunities to evaluate laboratory performance against peer institutions. These programs assess the laboratory's ability to produce accurate and reproducible IHC results using standardized samples.

Participation in quality assurance programs helps laboratories identify areas for improvement, validate internal quality control procedures, and maintain compliance with regulatory and accreditation standards.

Continuous quality improvement strengthens both laboratory performance and patient care.

Encourage Collaboration Between Laboratory Professionals

Successful use of IHC controls requires collaboration among pathologists, laboratory technologists, quality managers, and technical specialists. Open communication allows teams to investigate unexpected staining patterns, troubleshoot technical issues, and refine testing protocols.

Regular case reviews and quality meetings encourage knowledge sharing and continuous professional development, ultimately improving overall laboratory performance.

Conclusion

Using IHC controls effectively is fundamental to producing accurate, reproducible, and clinically meaningful immunohistochemistry results. Best laboratory practices include selecting validated control tissues, incorporating controls into every staining run, standardizing procedures, validating new reagents, maintaining equipment, documenting performance, and participating in quality assurance programs. By following these practices, laboratories can reduce technical errors, improve diagnostic confidence, and maintain the high standards required for modern pathology and research. Strong quality control practices ensure that IHC continues to serve as a reliable tool for disease diagnosis, treatment planning, and scientific discovery.